The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells.
The axis CXCL12-CXCR4 is highly expressed in ovarian cancer where contributes to disease progression. Aim of the work was to evaluate the effect of the newly developed CXCR4 antagonist R54 on human ovarian cancer cells aggressiveness. CXCL12-CXCR4 axis was evaluated in human ovarian cancer cells thr...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0314735 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841555461102370816 |
|---|---|
| author | Daniela Russo Anna Spina Luigi Portella Anna Maria Bello Francesca Galdiero Anna Maria Trotta Caterina Ieranò Giuseppina Rea Sabrina Chiara Cecere Elisabetta Coppola Salvatore Di Maro Sandro Pignata Daniela Califano Stefania Scala |
| author_facet | Daniela Russo Anna Spina Luigi Portella Anna Maria Bello Francesca Galdiero Anna Maria Trotta Caterina Ieranò Giuseppina Rea Sabrina Chiara Cecere Elisabetta Coppola Salvatore Di Maro Sandro Pignata Daniela Califano Stefania Scala |
| author_sort | Daniela Russo |
| collection | DOAJ |
| description | The axis CXCL12-CXCR4 is highly expressed in ovarian cancer where contributes to disease progression. Aim of the work was to evaluate the effect of the newly developed CXCR4 antagonist R54 on human ovarian cancer cells aggressiveness. CXCL12-CXCR4 axis was evaluated in human ovarian cancer cells through proliferation, migration and signaling CXCL12-dependents. Epithelial to mesenchymal transition (EMT) was analyzed through E-CADHERIN, N-CADHERIN, VIMENTIN, SNAIL1 and ΒETA-CATENIN by qRT-PCR, immunofluorescence and immunoblotting. R54 inhibited ovarian cancer cells proliferation and migration CXCL12-induced. Moreover, R54 inhibited CXCL12 dependent pERK1/2 and pAKT and reversed the CXCL12 induced EMT in ovarian cancer cells. Targeting CXCR4 with the new antagonist R54 consistently reverted the mesenchymal transition in human ovarian cancer cells reducing migratory and chemoresistance features. |
| format | Article |
| id | doaj-art-63d9516daf4840f3be1a6ca78a8fada4 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-63d9516daf4840f3be1a6ca78a8fada42025-01-08T05:32:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031473510.1371/journal.pone.0314735The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells.Daniela RussoAnna SpinaLuigi PortellaAnna Maria BelloFrancesca GaldieroAnna Maria TrottaCaterina IeranòGiuseppina ReaSabrina Chiara CecereElisabetta CoppolaSalvatore Di MaroSandro PignataDaniela CalifanoStefania ScalaThe axis CXCL12-CXCR4 is highly expressed in ovarian cancer where contributes to disease progression. Aim of the work was to evaluate the effect of the newly developed CXCR4 antagonist R54 on human ovarian cancer cells aggressiveness. CXCL12-CXCR4 axis was evaluated in human ovarian cancer cells through proliferation, migration and signaling CXCL12-dependents. Epithelial to mesenchymal transition (EMT) was analyzed through E-CADHERIN, N-CADHERIN, VIMENTIN, SNAIL1 and ΒETA-CATENIN by qRT-PCR, immunofluorescence and immunoblotting. R54 inhibited ovarian cancer cells proliferation and migration CXCL12-induced. Moreover, R54 inhibited CXCL12 dependent pERK1/2 and pAKT and reversed the CXCL12 induced EMT in ovarian cancer cells. Targeting CXCR4 with the new antagonist R54 consistently reverted the mesenchymal transition in human ovarian cancer cells reducing migratory and chemoresistance features.https://doi.org/10.1371/journal.pone.0314735 |
| spellingShingle | Daniela Russo Anna Spina Luigi Portella Anna Maria Bello Francesca Galdiero Anna Maria Trotta Caterina Ieranò Giuseppina Rea Sabrina Chiara Cecere Elisabetta Coppola Salvatore Di Maro Sandro Pignata Daniela Califano Stefania Scala The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. PLoS ONE |
| title | The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. |
| title_full | The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. |
| title_fullStr | The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. |
| title_full_unstemmed | The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. |
| title_short | The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. |
| title_sort | cxcr4 antagonist r54 targets epithelial mesenchymal transition emt in human ovarian cancer cells |
| url | https://doi.org/10.1371/journal.pone.0314735 |
| work_keys_str_mv | AT danielarusso thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT annaspina thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT luigiportella thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT annamariabello thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT francescagaldiero thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT annamariatrotta thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT caterinaierano thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT giuseppinarea thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT sabrinachiaracecere thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT elisabettacoppola thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT salvatoredimaro thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT sandropignata thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT danielacalifano thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT stefaniascala thecxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT danielarusso cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT annaspina cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT luigiportella cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT annamariabello cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT francescagaldiero cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT annamariatrotta cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT caterinaierano cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT giuseppinarea cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT sabrinachiaracecere cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT elisabettacoppola cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT salvatoredimaro cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT sandropignata cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT danielacalifano cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells AT stefaniascala cxcr4antagonistr54targetsepithelialmesenchymaltransitionemtinhumanovariancancercells |